When.com Web Search

  1. Ads

    related to: car t therapy side effects for bowel problems in women treatment

Search results

  1. Results From The WOW.Com Content Network
  2. CAR T cell - Wikipedia

    en.wikipedia.org/wiki/CAR_T_cell

    Depiction of adoptive cell transfer therapy with CAR-engineered T cells. The first step in the production of CAR T-cells is the isolation of T cells from human blood. CAR T-cells may be manufactured either from the patient's own blood, known as an autologous treatment, or from the blood of a healthy donor, known as an allogeneic treatment. The ...

  3. Cellular adoptive immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Cellular_adoptive...

    A major application of cellular adoptive therapy is cancer treatment, as the immune system plays a vital role in the development and growth of cancer. [1] The primary types of cellular adoptive immunotherapies are T cell therapies. Other therapies include CAR-T therapy, CAR-NK therapy, macrophage-based immunotherapy and dendritic cell therapy.

  4. FDA says cancer treatment CAR-T therapy may increase ... - AOL

    www.aol.com/news/fda-says-cancer-treatment-car...

    CAR-T — or chimeric antigen receptor T cell — therapy uses a patient’s own immune cells to treat certain blood cancers, such as leukemia, multiple myeloma and lymphoma. It involves ...

  5. Immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Immunotherapy

    Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system. Immunotherapy is designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies .

  6. US FDA investigating safety risk of CAR-T cancer therapies - AOL

    www.aol.com/news/us-fda-investigating-safety...

    The U.S. Food and Drug Administration (FDA) said on Tuesday it was investigating cancer therapies made by Gilead Sciences, Johnson & Johnson, Novartis and others over the risk of hospitalizations ...

  7. Kymriah, the first CAR-T cancer therapy approved by the FDA for leukemia treatment, was approved in 2017. The initial approvals of these treatments included an FDA requirement for 15-year follow ...